Open AccessA Phase I/II Study Comparing Regimen Schedules of Gemcitabine and Docetaxel in Japanese Patients with Stage IIIB/IV Non-small Cell Lung Cancer
Author(s) -
Kunihiko Matsui,
Tomonori Hirashima,
Takashi Nitta,
Masashi Kobayashi,
Yoshitaka Ogata,
Mitsugi Furukawa,
Shinzoh Kudoh,
Naoki Yoshimura,
Toru Mukohara,
Setsuko Yamauchi,
Satoshi Shiraishi,
Hiroshi Kamoi,
Shunichi Negoro,
Kouji Takeda,
Kazuhiko Nakagawa,
Minoru Takada,
Takashi Yana,
Masahiro Fukuoka
Publication year - 2005
Publication title -
japanese journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.768
H-Index - 85
eISSN - 1465-3621
pISSN - 0368-2811
DOI - 10.1093/jjco/hyi057
Subject(s) - docetaxel , gemcitabine , medicine , regimen , lung cancer , phases of clinical research , oncology , chemotherapy , gastroenterology
Gemcitabine and docetaxel are non-platinum agents with activity in non-small cell lung cancer (NSCLC). This study was conducted to determine and evaluate the recommended regimen of gemcitabine-docetaxel and evaluated its efficacy and safety in chemonaive Japanese NSCLC patients.